Αρχειοθήκη ιστολογίου

Δευτέρα 6 Αυγούστου 2018

Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England

Tikhonova, IA; Huxley, N; Snowsill, T; Crathorne, L; Varley-Campbell, J; Napier, M; Hoyle, M; (2018) Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England. PharmacoEconomics , 36 (7) pp. 837-851. 10.1007/s40273-018-0630-9 .

https://ift.tt/2ALWipz

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου